Molander, D., Sbirkov, Y., Sarafian, V. 3D bioprinting as an emerging standard for cancer modeling and drug testing,
, 2022, 559-565.
Molander, D., Sbirkov, Y., Sarafian, V. .
3D bioprinting as an emerging standard for cancer modeling and drug testing.
Plovdiv: , 2022, 559-565.
Molander, D., Sbirkov, Y., Sarafian, V. (2022)
3D bioprinting as an emerging standard for cancer modeling and drug testing,
Plovdiv: , 559-565
Molander, D.,
Sbirkov, Y., &
Sarafian, V.
(2022).
3D bioprinting as an emerging standard for cancer modeling and drug testing. Folia Medica. Plovdiv: 64 (4), 559-565.